Marrow morphology of chronic myelogenous leukemia in patients treated with imatinib mesylate (Gleevac, Sti-571): Correlation with cytogenetic response

被引：0
|
作者：
Racke, F
Allan, RW
Miller, C
Weir, EG
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[2] St Agnes Hosp, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1148
引用
收藏
页码：248A / 248A
页数：1
相关论文
共 50 条
  • [31] Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate
    Anthony, Navin
    Shanks, James
    Terebelo, Howard
    LEUKEMIA RESEARCH, 2010, 34 (09) : 1250 - 1251
  • [32] Assessment of fibrosis and vascularization of bone marrow stroma of Chronic Myeloid Leukemia patients treated with imatinib mesylate and their relationship with the cytogenetic response
    de Jesus, Caroline Regina
    I-Ching, Lee
    Carvalho Neiva, Teresinha de Jesus
    Vituri, Cidonia de Lourdes
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 47 (02) : 313 - 322
  • [33] Risk factors for myelosuppression in chronic phase CML patients treated with Imatinib mesylate (STI571).
    Mauro, MJ
    O'Dwyer, ME
    Kurilik, G
    Blasdel, C
    Farnsworth, M
    Fong, D
    Hsieh, YC
    Mori, M
    Ford, JM
    Druker, BJ
    BLOOD, 2001, 98 (11) : 139A - 139A
  • [34] Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: Rapid response to imatinib mesylate (STI571)
    Imashuku, S
    Morimoto, A
    Kuriyama, K
    Kano, G
    Hibi, S
    Todo, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (02): : 159 - +
  • [35] Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate
    Yoon, Ju-Yoon
    Kumar, Rajat
    Aloyz, Raquel
    Johnston, James B.
    LEUKEMIA RESEARCH, 2011, 35 (09) : E179 - E180
  • [36] Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis
    Koh, LP
    Hwang, WYK
    Chuah, CTH
    Linn, YC
    Goh, YT
    Tan, CH
    Ng, HJ
    Tan, PHC
    BONE MARROW TRANSPLANTATION, 2003, 31 (04) : 305 - 308
  • [37] Morphologic findings in peripheral blood and bone marrow of STI571-treated chronic myelogenous leukemia patients.
    Launder, TM
    Druker, BJ
    Mauro, MJ
    O'Dwyer, ME
    Resta, D
    Braziel, RM
    BLOOD, 2000, 96 (11) : 735A - 735A
  • [38] Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia
    Bueso-Ramos, CE
    Cortes, J
    Talpaz, M
    O'Brien, S
    Giles, F
    Rios, MB
    Medeiros, LJ
    Kantarjian, H
    CANCER, 2004, 101 (02) : 332 - 336
  • [39] Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis
    L P Koh
    W Y K Hwang
    C T H Chuah
    Y C Linn
    Y T Goh
    C H Tan
    H J Ng
    P H C Tan
    Bone Marrow Transplantation, 2003, 31 : 305 - 308
  • [40] Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
    Cortes, JE
    Talpaz, M
    Giles, F
    O'Brien, S
    Rios, MB
    Shan, J
    Garcia-Manero, G
    Faclerl, S
    Thomas, DA
    Wierda, W
    Ferrajoli, A
    Jeha, S
    Kantarjian, HM
    BLOOD, 2003, 101 (10) : 3794 - 3800
12345